|
G |
ABCC3 |
ATP binding cassette subfamily C member 3 |
increases activity affects export multiple interactions |
EXP ISO |
acetaminophen glucuronide results in increased activity of ABCC3 protein ABCC3 protein affects the export of acetaminophen glucuronide Ethinyl Estradiol promotes the reaction [ABCC3 protein results in increased secretion of acetaminophen glucuronide] |
CTD |
PMID:16250050 PMID:16554369 PMID:17569508 |
|
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
|
|
G |
INS |
insulin |
increases abundance |
EXP |
INS protein results in increased abundance of acetaminophen glucuronide |
CTD |
PMID:26739624 |
|
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
|
|
G |
OGT |
O-linked N-acetylglucosamine (GlcNAc) transferase |
multiple interactions |
ISO |
OGT gene mutant form inhibits the reaction [Acetaminophen results in increased abundance of acetaminophen glucuronide] |
CTD |
PMID:29325178 |
|
NCBI chr X:71,533,104...71,575,892
Ensembl chr X:71,533,087...71,575,892
|
|
|
G |
KL |
klotho |
multiple interactions |
ISO |
androsterone glucuronide inhibits the reaction [KL protein results in increased hydrolysis of Glucuronides] |
CTD |
PMID:14701853 |
|
NCBI chr13:33,016,243...33,066,143
Ensembl chr13:33,016,423...33,066,143
|
|
|
G |
PPARGC1A |
PPARG coactivator 1 alpha |
increases expression |
EXP |
glucuronolactone results in increased expression of PPARGC1A mRNA |
CTD |
PMID:23056435 |
|
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
|
|
|
G |
AKR1A1 |
aldo-keto reductase family 1 member A1 |
increases reduction |
EXP ISO |
AKR1A1 protein results in increased reduction of Glucuronic Acid |
CTD |
PMID:10510318 PMID:29763686 |
|
NCBI chr 1:45,550,826...45,570,049
Ensembl chr 1:45,550,543...45,570,049
|
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
increases expression affects transport |
ISO |
bilirubin glucuronate results in increased expression of ABCC2 mRNA ABCC2 protein affects the transport of bilirubin glucuronate |
CTD |
PMID:11897625 PMID:16611851 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
POR |
cytochrome p450 oxidoreductase |
increases abundance |
ISO |
POR gene mutant form results in increased abundance of bilirubin glucuronate |
CTD |
PMID:25147274 |
|
NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
|
|
|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
multiple interactions |
EXP |
[NADP co-treated with Uridine Diphosphate Glucuronic Acid co-treated with Phosphoadenosine Phosphosulfate] promotes the reaction [[Enzymes and Coenzymes results in increased metabolism of diosbulbin B] inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid]]; [NADP co-treated with Uridine Diphosphate Glucuronic Acid co-treated with Phosphoadenosine Phosphosulfate] promotes the reaction [[Enzymes and Coenzymes results in increased metabolism of saikogenin A analog] inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid]]; [NADP co-treated with Uridine Diphosphate Glucuronic Acid co-treated with Phosphoadenosine Phosphosulfate] promotes the reaction [[Enzymes and Coenzymes results in increased metabolism of saikogenin A] inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid]] |
CTD |
PMID:35101544 |
|
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
B3GAT3 |
beta-1,3-glucuronyltransferase 3 |
affects binding multiple interactions |
EXP |
B3GAT3 protein binds to Uridine Diphosphate Glucuronic Acid Uridine Diphosphate Glucuronic Acid inhibits the reaction [Diacetyl results in decreased activity of B3GAT3 protein] |
CTD |
PMID:11986319 |
|
NCBI chr11:62,615,296...62,621,986
Ensembl chr11:62,615,296...62,622,154
|
|
G |
GALE |
UDP-galactose-4-epimerase |
affects binding |
EXP |
Uridine Diphosphate Glucuronic Acid binds to GALE protein |
CTD |
PMID:25526675 |
|
NCBI chr 1:23,795,599...23,800,754
Ensembl chr 1:23,795,599...23,800,781
|
|
G |
PPARGC1A |
PPARG coactivator 1 alpha |
increases expression |
EXP |
Uridine Diphosphate Glucuronic Acid results in increased expression of PPARGC1A mRNA |
CTD |
PMID:23056435 |
|
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
|
|
G |
UGT1A1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions |
EXP |
[Uridine Diphosphate Glucuronic Acid co-treated with UGT1A1 protein] results in increased glucuronidation of Labetalol |
CTD |
PMID:18098064 |
|
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
|
|
G |
UGT1A3 |
UDP glucuronosyltransferase family 1 member A3 |
multiple interactions |
EXP |
[Uridine Diphosphate Glucuronic Acid co-treated with UGT1A3 protein] results in increased metabolism of Lithocholic Acid |
CTD |
PMID:36473578 |
|
NCBI chr 2:233,729,042...233,773,300
Ensembl chr 2:233,729,042...233,773,300
|
|
G |
UGT2B7 |
UDP glucuronosyltransferase family 2 member B7 |
multiple interactions |
EXP |
[Uridine Diphosphate Glucuronic Acid co-treated with UGT2B7 protein] results in increased glucuronidation of Labetalol; [Uridine Diphosphate Glucuronic Acid co-treated with UGT2B7 protein] results in increased metabolism of hyodeoxycholic acid; Fluconazole inhibits the reaction [[Uridine Diphosphate Glucuronic Acid co-treated with UGT2B7 protein] results in increased glucuronidation of Labetalol] |
CTD |
PMID:18098064 PMID:36473578 |
|
NCBI chr 4:69,051,375...69,112,987
Ensembl chr 4:69,051,363...69,112,987
|
|
G |
UXS1 |
UDP-glucuronate decarboxylase 1 |
multiple interactions |
EXP |
[Uridine Diphosphate Glucuronic Acid co-treated with NAD] binds to UXS1 protein |
CTD |
PMID:25526675 |
|
NCBI chr 2:106,093,311...106,194,301
Ensembl chr 2:106,093,308...106,194,301
|
|